NEW YORK (GenomeWeb News) – The Sanford-Burnham Medical Research Institute said today that its investigators will collaborate with Pfizer to identify therapeutic targets for use in preventing and treating complications related to obesity and diabetes.

Under the three-year collaboration, the partners at Pfizer and Sanford-Burnham's Conrad Prebys Center for Chemical Genomics will use novel screening tools and systems biology approaches to develop treatment methods for reducing insulin resistance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.